Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i


Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
  • Published Date:

    Mar 2011

  • Source:
    Curr Drug Abuse Rev. 2011; 4(1):28-41
  • Language:
    English
Filetype[PDF-90.25 KB]


Details:
No Related Documents.

You May Also Like:

  1. Corporate Authors:
    National Center for Injury Prevention and Control (U.S.)
    Published Date:
    08/06/2019
    Series:
    CDC Vital signs ; 2019 Aug.
    Description:
    About 48,000 US drug overdose deaths involved opioids in 2017. Naloxone is a life-saving medication that can reverse the effects of an opioid overdose...
    File Type:
    Filetype[PDF - 448.83 KB]
    File Type:
    Filetype[PDF - 448.83 KB]
  2. Personal Author:
    Dowell, Deborah ; Noonan, Rita K. ; ...
    Published Date:
    Dec 19 2017
    Source:
    JAMA. 318(23):2295-2296
    File Type:
    Filetype[PDF - 166.54 KB]
    File Type:
    Filetype[PDF - 166.54 KB]
  3. Personal Author:
    Green, Traci C. ; Zaller, Nickolas ; ...
    Published Date:
    Sep 02 2013
    Source:
    Drug Alcohol Depend. 2013; 133(2):677-684.
    Description:
    BackgroundLaw enforcement is often the first to respond to medical emergencies in the community, including overdose. Due to the nature of their job, o...
    File Type:
    Filetype[PDF - 121.11 KB]
    File Type:
    Filetype[PDF - 121.11 KB]
  4. Personal Author:
    Gery P. Guy Jr., ; Tamara M. Haegerich, ; ...
    Corporate Authors:
    National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention. ; United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health Sciences. ;
    Published Date:
    August 6, 2019
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 68, early release, August 6, 2019
    CDC Vital signs ; Aug. 2019
    Description:
    Background: The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for...
    File Type:
    Filetype[PDF - 2.86 MB]
    File Type:
    Filetype[PDF - 2.86 MB]
  5. Corporate Authors:
    National Center for Injury Prevention and Control (U.S.) ; Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communications. ;
    Published Date:
    March 6, 2018
    Series:
    CDC Vital signs ; Mar. 2018
    Description:
    Emergency department (ED) visits for opioid* overdoses rose 30% in all parts of the US from July 2016 through September 2017. People who have had an o...
    File Type:
    Filetype[PDF - 1.18 MB]
    File Type:
    Filetype[PDF - 1.18 MB]